A detailed history of Western Financial Corporation transactions in Eli Lilly & CO stock. As of the latest transaction made, Western Financial Corporation holds 3,306 shares of LLY stock, worth $2.8 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
3,306
Previous 3,021 9.43%
Holding current value
$2.8 Million
Previous $979,000 9.19%
% of portfolio
0.75%
Previous 0.7%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

BUY
$296.48 - $337.87 $84,496 - $96,292
285 Added 9.43%
3,306 $1.07 Million
Q2 2022

Jul 22, 2022

BUY
$278.73 - $327.27 $842,043 - $988,682
3,021 New
3,021 $979,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $805B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Western Financial Corporation Portfolio

Follow Western Financial Corporation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Financial Corporation, based on Form 13F filings with the SEC.

News

Stay updated on Western Financial Corporation with notifications on news.